2024 AACR-KCA Joint Conference on Precision Medicine in Cancer November 21(Thu) – 22(Fri), 2024 | Lotte Hotel Seoul, Korea

Call for Abstracts *All fields below should be filled in English.

* Presentation Type
* Abstract Topic
*Abstract Title
Capitalize the first letter of the sentence only
*List of Authors
Presenting author's name will be underlined. Corresponding author's name will be marked by asterisk (*) following the name.
e.g. Gil Dong Hong¹, Michael J. Lee²,*
*Authors' Affiliation
e.g. ¹Department of Preventive Medicine, ○○ University College of Medicine, Kyongju, Korea; ²Department of Preventive Medicine and ³General Surgery, Seoul National University College of Medicine, Seoul, Korea.
*Text(400-words limit)
Purpose-Methods-Results-Conclusions (Those four words should be included in the text)
*Conflict of Interest
*Disclosure of the Structure of Chemical Compounds
AACR-KCA Policy on Disclosure of the Structure of Chemical Compounds

Disclosure of complete chemical structures of compounds used in the conduct of research is essential for the comprehensive scientific assessment of proffered papers and ensuring high-quality scientific presentations at AACR-KCA meetings.

Chemical compounds are defined as low molecular weight (generally <1000g/mol) organic or inorganic molecules, peptides, or proteins/nucleic acids co-crystallized with low molecular weight molecules.

At the time of abstract submission, the submitting author is required to state whether chemical compounds were used in the scientific work to generate the data in the proffered paper. If so, the corresponding author is further required to indicate whether the complete chemical structures of the compounds used will be disclosed at the time of presentation at the meeting. The chemical structures are not required to be included at the time of abstract submission; rather, indication of the intent to disclose any such structures at the time of presentation is required.

The Abstract Review Committee will then evaluate the information provided by the submitting author and determine the acceptability of the proffered paper for presentation.

Please explain why you do not intend to disclose the relevant chemical structures during your presentation at the meeting. If needed, enter the literature reference and/or patent application number for the structure in question. Your explanation and reference information will be made available to the Scientific Review Committee members responsible for reviewing your abstract.

*Apply for Abstract Award

The AACR and KCA will be offering a limited number of Abstract Awards for early-career presenters of meritorious abstracts.

Eligible individuals will be selected based on the quality of their abstract.
To be considered for an award, an individual must:


Be 45 years of age or younger at the time of the conference


NOT be employees or subcontractors of for-profit, private industry

Please select Yes/No to certify that you meet these eligibility criteria and would like to be considered for an Abstract Award.

Author’s Information

*First(Given) Name
*Last(Family) Name
국문명(Korean Only)
*e.g. 000 Hospital, 000 Institute, 000 University
+ -
*e.g. +82-2-123-1234
+ -
*e.g. +82-10-1234-1234
Corresponding Author

*First Name

*Last Name

국문명(Korean Only)



More than 4 letters and less than 12 ones, English letters and Numbers, no blank
(Necessary for abstract revision - please enter it accurately)

Co-hosted by
American Association for Cancer Research
615 Chestnut St., 17th Floor
Philadelphia, PA 19106-4404 USA
TEL: +1 215-440-9300
Email: aacr@aacr.org
Korean Cancer Association
Rm. 1824, Gwanghwamun Officia, 92 Saemunan-ro,
Jongno-gu, Seoul 03186, Korea
TEL: +82 (0)2-792-1486
E-mail: cancer@kams.or.kr
2024 AACR-KCA Secretariat
AIM Korea Corp.
TEL: +82 (0)70-8768-9986
General Inquiries: info@aacr-kca.org
Abstract Inquiries: abstract@aacr-kca.org
Program & Speakers: scientific@aacr-kca.org